newsfilter
← Latest News
Business Wire·

NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration

EHR-enabled access has the potential to streamline ordering, accelerate clinical decisions, and drive scalable precision oncology adoption NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic